---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-001550"
form_type: "8-K"
ticker: "PMCB"
cik: "0001157075"
company_name: "PharmaCyte Biotech, Inc."
filed_at: "2022-03-09T23:59:59+00:00"
generated_at: "2026-06-27T00:18:30.004493+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# PharmaCyte Biotech posts corporate presentation on its website; no financial or clinical updates disclosed.

## Summary
- Company made a corporate presentation available on its website for investor and analyst use.
- Presentation contains standard forward-looking statements and disclaimers; no specific figures or milestones provided.
- No material new information about pipeline, financials, or business developments was disclosed.

## SEC filing metadata
- accession: 0001683168-22-001550
- form_type: 8-K
- ticker: PMCB
- cik: 0001157075
- company_name: PharmaCyte Biotech, Inc.
- filed_at: 2022-03-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157075/000168316822001550/0001683168-22-001550-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157075/000168316822001550/pharmacyte_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-001550
- JSON: https://secwatch.observer/filing/0001683168-22-001550.json
- Plain text: https://secwatch.observer/filing/0001683168-22-001550.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.